Skip to main content
Find more clinical trials

Study to Evaluate Amyloid in Blood and Imaging Related to Dementia (SEABIRD)

Start: April 2019
End: August 2023
Enrollment: 1120

What Is This Study About?

This study will evaluate a blood test for detecting amyloid-beta, a protein involved in Alzheimer's disease, in older adults. Researchers are recruiting people with and without memory problems to investigate the ability of the blood test to detect this protein in order to screen people for early signs of the disease. Participants will undergo blood collection and cognitive testing, and may be asked to undergo brain imaging.

Do I Qualify To Participate in This Study?

Minimum Age: 60 Years

Maximum Age: N/A

Must have:

  • None

Must NOT have:

  • Unable to perform one or more activities of daily living, such as eating, bathing, dressing, walking, and toileting) or dependent on others due to cognitive impairment
  • Weigh less than 100 pounds
  • Active infectious disease, such as HIV, hepatitis B, or hepatitis C
  • Bleeding disorder
  • Pacemaker
  • Taking an experimental drug for Alzheimer's disease
  • Blood donation in the last 2 months
  • Blood transfusion in the last 3 months
  • On hospice
 
Study Contact
Melinda Hamilton
Tinishia Greene

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Missouri
Washington University School of Medicine
Saint Louis, MO 63110
Recruiting
Melinda Hamilton

Who Sponsors This Study?

Lead: Washington University School of Medicine

Source: ClinicalTrials.gov ID: NCT03899844